These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage. Bahra M; Neumann UP; Harren M; Jacob D; Langrehr JM; Berg T; Neuhaus R; Neuhaus P Transplant Proc; 2002 Nov; 34(7):2934-5. PubMed ID: 12431663 [No Abstract] [Full Text] [Related]
10. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation. Reggiani P; Arru M; Regazzi M; Gatti S; Molinaro MD; Caccamo L; Maggi U; Melada E; Paone G; Rossi G Transplant Proc; 2005 May; 37(4):1697-9. PubMed ID: 15919435 [TBL] [Abstract][Full Text] [Related]
13. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. Ringe B; Braun F; Schütz E; Füzesi L; Lorf T; Canelo R; Oellerich M; Ramadori G Transplantation; 2001 Feb; 71(4):508-15. PubMed ID: 11258429 [TBL] [Abstract][Full Text] [Related]
14. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids. Asensio M; Margarit C; Chavez R; Ortega J; Charco R; Iglesias J Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650 [No Abstract] [Full Text] [Related]
15. How to handle mycophenolate mofetil in combination with tacrolimus? Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309 [No Abstract] [Full Text] [Related]
16. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538 [TBL] [Abstract][Full Text] [Related]
17. Indications for mycofenolate mofetil therapy after liver transplantation. Platz KP; Mueller AR; Neuhaus P Transplant Proc; 1997 Nov; 29(7):2880-1. PubMed ID: 9365601 [No Abstract] [Full Text] [Related]
18. Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient. Iglesias J; Ortega J; López JA; Sánchez L; Allende E; Asensio M; Margarit C Transpl Int; 2003 Oct; 16(10):765-7. PubMed ID: 12827229 [No Abstract] [Full Text] [Related]
19. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus. Hunt SA Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892 [TBL] [Abstract][Full Text] [Related]
20. Reversal of chronic rejection after treatment failure with FK506 and RS61443. Roberts JP; Lake JR; Hebert M; Nikolai B; Ascher NL; Ferrell LD Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634 [No Abstract] [Full Text] [Related] [Next] [New Search]